Waldenstrom Macroglobulinaemia

Explore clinical trials studying Waldenstrom Macroglobulinaemia. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Waldenstrom Macroglobulinaemia trial results

Recruiting

NCT06544265

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations: Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

The University of Kansas Cancer Center Fairway, Kansas, United States

Rutgers Cancer Institute New Brunswick, New Jersey, United States

Recruiting

NCT07160270

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Copenhagen Neuromuscular Center, Rigshospitalet Blegdamsvej. København Ø, Denmark

Recruiting

NCT06550427

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: National Taiwan University Hospital Taipei, Taiwan

Not Yet Recruiting

NCT07592481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
Locations: Not specified

Not Yet Recruiting

NCT07474961

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Copenhagen University Hospital - Rigshospitalet Copenhagen, Greater Copenhagen Area, Denmark

Aalborg University Hospital Aalborg, Denmark

Aarhus University Hospital Aarhus, Denmark

Odense University Hospital Odense, Denmark

Completed

NCT00811733

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Stanford, California, United States

GSK Investigational Site Rochester, Minnesota, United States

GSK Investigational Site Buffalo, New York, United States